Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised …

…, W Ruksakul, C Sangketchon… - The Lancet Infectious …, 2024 - thelancet.com
Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …

Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)

…, J Tarning, WRJ Taylor, V Chotivanich, C Sangketchon… - ELife, 2023 - elifesciences.org
Background: There is no generally accepted methodology for in vivo assessment of antiviral
activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment …

Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)

…, V Chotivanich, C Sangketchon… - The Journal of …, 2023 - academic.oup.com
Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a …

…, W Ruksakul, C Sangketchon - The Lancet Infectious …, 2024 - thelancet.com
Background Effective antiviral drugs prevent hospitalisation and death from COVID-19.
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …

Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants

…, WRJ Taylor, V Chotivanich, C Sangketchon… - medRxiv, 2022 - medrxiv.org
Background Uncertainty over the therapeutic benefit provided by parenteral remdesivir in
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …

Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19

…, J Tarning, WRJ Taylor, V Chotivanich, C Sangketchon… - medRxiv, 2022 - medrxiv.org
Background There is no generally accepted methodology for in vivo assessment of antiviral
activity in SARS-CoV-2 infection. Ivermectin has been recommended widely as a treatment …

Perception and satisfaction of patients' relatives regarding emergency medical service response times: a cross-sectional study

T Huabbangyang, C Sangketchon… - Open Access …, 2022 - Taylor & Francis
Purpose Delays in emergency medical service (EMS) directly affect life-threatening
emergencies. Delays also indirectly affect the perception and satisfaction of patients and their …

[HTML][HTML] Predictive factors of outcome in cases of out-of-hospital cardiac arrest due to traffic accident injuries in Thailand; a national database study

T Huabbangyang, C Sangketchon… - Archives of academic …, 2022 - ncbi.nlm.nih.gov
Methods: This retrospective cross-sectional study was conducted on cases of OHCA due to
traffic accident, who were resuscitated at the scene by emergency medical services (EMS) in …

Presentation, clinical characteristics, and treatment outcomes among tuberculous meningitis patients with and without HIV infection at vajira hospital, Thailand: a …

L Boonyagars, C Sangketchon… - Journal of the …, 2021 - journals.sagepub.com
To compare the characteristics, presentation, investigations, and outcomes in tuberculous
meningitis (TBM) patients with and without human immunodeficiency virus (HIV) coinfection. A …

[HTML][HTML] Efficacy of SARS-CoV-2 detection from used surgical masks compared with standard detection method

…, Y Apichatbutr, K Pholtawornkulchai, C Sangketchon… - Biosafety and …, 2024 - Elsevier
The real-time reverse transcription-polymerase chain reaction (RT-PCR) test is the gold
standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. Proper …